Clinical Trial

The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )

Study acronym: OTAtosiban
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human top-down attention via oxytocin receptors and whether its effects are dose- and task-dependent.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-18; most recent amendment 2025-09-05.
Trial Details
NCT Number NCT07140237
Lead Sponsor University of Electronic Science and Technology of China
Conditions Healthy Adult Male
Enrollment 250 participants
Start Date 2025-09
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-08